Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10617701B2 · kind B2 · utility
0Cited by
20References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2015 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | Dec 24, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2250/54248
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a composition and method for promoting functional neuronal development in pediatric subjects. The composition comprises in some embodiments up to about 7 g/100 Kcal of a fat or lipid source; up to about 5 g/100 Kcal of a protein source; about 3 mg/100 Kcal to about 50 mg/100 Kcal of phosphatidylethanolamine; about 0.15 mg/100 Kcal to about 75 mg/100 Kcal of sphingomyelin; and about 5 mg/100 Kcal to about 75 mg/100 Kcal of docosahexaenoic acid. The methods comprise, in some embodiments, administering the aforementioned composition to a pediatric subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.